| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalomyelitis, Autoimmune, Experimental | 115 | 2023 | 834 | 11.940 |
Why?
|
| Th17 Cells | 47 | 2023 | 765 | 9.630 |
Why?
|
| Autoimmunity | 62 | 2023 | 1348 | 7.240 |
Why?
|
| Interleukin-17 | 54 | 2023 | 900 | 6.510 |
Why?
|
| T-Lymphocytes, Regulatory | 83 | 2022 | 2986 | 6.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 47 | 2021 | 986 | 5.870 |
Why?
|
| Th1 Cells | 43 | 2023 | 1056 | 5.260 |
Why?
|
| T-Lymphocyte Subsets | 46 | 2023 | 1837 | 4.750 |
Why?
|
| Autoimmune Diseases | 44 | 2023 | 2130 | 4.620 |
Why?
|
| Receptors, Virus | 36 | 2016 | 648 | 4.330 |
Why?
|
| Interleukin-10 | 39 | 2022 | 1200 | 4.090 |
Why?
|
| T-Lymphocytes | 103 | 2023 | 10163 | 4.080 |
Why?
|
| Interleukins | 21 | 2023 | 791 | 3.710 |
Why?
|
| Lymphocyte Activation | 94 | 2023 | 5519 | 3.580 |
Why?
|
| Cell Differentiation | 77 | 2023 | 11470 | 3.330 |
Why?
|
| Myelin Proteolipid Protein | 35 | 2011 | 107 | 2.940 |
Why?
|
| CD4-Positive T-Lymphocytes | 42 | 2022 | 4379 | 2.920 |
Why?
|
| Receptors, Immunologic | 17 | 2020 | 1423 | 2.910 |
Why?
|
| Receptors, Interleukin | 16 | 2022 | 245 | 2.700 |
Why?
|
| Th2 Cells | 24 | 2019 | 1049 | 2.670 |
Why?
|
| Membrane Proteins | 51 | 2023 | 7873 | 2.660 |
Why?
|
| Inflammation | 43 | 2023 | 10578 | 2.440 |
Why?
|
| Mice | 298 | 2023 | 81045 | 2.320 |
Why?
|
| Animals | 372 | 2023 | 168561 | 2.230 |
Why?
|
| Mice, Inbred C57BL | 129 | 2023 | 21821 | 2.130 |
Why?
|
| Galectins | 17 | 2014 | 267 | 2.100 |
Why?
|
| Cytokines | 69 | 2023 | 7317 | 2.060 |
Why?
|
| Immune Tolerance | 38 | 2019 | 2257 | 2.040 |
Why?
|
| Interleukin-23 | 17 | 2022 | 193 | 1.960 |
Why?
|
| Multiple Sclerosis | 31 | 2022 | 3076 | 1.910 |
Why?
|
| Forkhead Transcription Factors | 28 | 2017 | 1613 | 1.910 |
Why?
|
| Autoantigens | 20 | 2019 | 891 | 1.790 |
Why?
|
| B-Lymphocytes | 15 | 2023 | 4664 | 1.700 |
Why?
|
| Antigens, CD | 35 | 2021 | 4024 | 1.680 |
Why?
|
| CD8-Positive T-Lymphocytes | 23 | 2023 | 4438 | 1.660 |
Why?
|
| Receptors, Antigen, T-Cell | 37 | 2021 | 2524 | 1.650 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 15 | 2013 | 906 | 1.640 |
Why?
|
| Gene Regulatory Networks | 8 | 2020 | 1707 | 1.590 |
Why?
|
| Antigen-Presenting Cells | 17 | 2012 | 969 | 1.560 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 22 | 2011 | 804 | 1.450 |
Why?
|
| Mice, Knockout | 72 | 2023 | 14554 | 1.370 |
Why?
|
| Lymphocytes | 4 | 2023 | 2614 | 1.370 |
Why?
|
| Peptide Fragments | 40 | 2020 | 5095 | 1.330 |
Why?
|
| Mice, Transgenic | 67 | 2023 | 9735 | 1.300 |
Why?
|
| Colitis | 10 | 2022 | 1149 | 1.300 |
Why?
|
| Membrane Glycoproteins | 26 | 2014 | 3769 | 1.250 |
Why?
|
| Interleukin-2 | 18 | 2019 | 1887 | 1.220 |
Why?
|
| Signal Transduction | 58 | 2020 | 23387 | 1.160 |
Why?
|
| Myelin Proteins | 22 | 2009 | 215 | 1.150 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 10 | 2016 | 140 | 1.150 |
Why?
|
| Interferon-gamma | 38 | 2021 | 3199 | 1.110 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 3 | 2017 | 154 | 1.080 |
Why?
|
| Gene Expression Regulation | 32 | 2019 | 12071 | 1.070 |
Why?
|
| Proto-Oncogene Proteins c-maf | 5 | 2018 | 71 | 1.070 |
Why?
|
| Autoantibodies | 14 | 2020 | 2036 | 1.040 |
Why?
|
| Transforming Growth Factor beta | 22 | 2017 | 2006 | 1.010 |
Why?
|
| STAT1 Transcription Factor | 6 | 2018 | 320 | 1.000 |
Why?
|
| Neuropeptides | 3 | 2019 | 942 | 0.980 |
Why?
|
| Molecular Chaperones | 3 | 2022 | 742 | 0.980 |
Why?
|
| Fibrinogen | 2 | 2020 | 894 | 0.970 |
Why?
|
| Dendritic Cells | 16 | 2023 | 2723 | 0.940 |
Why?
|
| Antigens, Differentiation | 10 | 2005 | 926 | 0.890 |
Why?
|
| Myelin-Associated Glycoprotein | 11 | 2009 | 113 | 0.880 |
Why?
|
| Cells, Cultured | 50 | 2019 | 19223 | 0.870 |
Why?
|
| Amino Acid Sequence | 60 | 2018 | 13814 | 0.860 |
Why?
|
| Central Nervous System | 15 | 2023 | 1354 | 0.860 |
Why?
|
| Interleukin-4 | 16 | 2022 | 1146 | 0.860 |
Why?
|
| Ribonucleoproteins | 12 | 2018 | 381 | 0.830 |
Why?
|
| Immunity, Innate | 17 | 2023 | 2956 | 0.820 |
Why?
|
| Intestines | 5 | 2021 | 1923 | 0.820 |
Why?
|
| Ligands | 25 | 2019 | 3293 | 0.810 |
Why?
|
| Antibodies, Monoclonal | 38 | 2023 | 9274 | 0.790 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 2019 | 305 | 0.780 |
Why?
|
| Molecular Sequence Data | 59 | 2015 | 18112 | 0.770 |
Why?
|
| Transcription Factors | 19 | 2021 | 12164 | 0.770 |
Why?
|
| Major Histocompatibility Complex | 10 | 2012 | 935 | 0.760 |
Why?
|
| Adoptive Transfer | 25 | 2015 | 844 | 0.760 |
Why?
|
| Antibody Formation | 7 | 2020 | 1402 | 0.750 |
Why?
|
| STAT3 Transcription Factor | 12 | 2018 | 874 | 0.750 |
Why?
|
| Organ Specificity | 4 | 2021 | 2003 | 0.750 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2017 | 246 | 0.740 |
Why?
|
| Apoptosis Regulatory Proteins | 8 | 2015 | 1158 | 0.730 |
Why?
|
| Neoplasms | 12 | 2023 | 21596 | 0.730 |
Why?
|
| Diabetes Mellitus, Type 1 | 14 | 2015 | 3336 | 0.710 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2019 | 29 | 0.710 |
Why?
|
| Mucus | 1 | 2021 | 321 | 0.710 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 3 | 2016 | 18 | 0.690 |
Why?
|
| Interleukin-12 | 4 | 2014 | 579 | 0.680 |
Why?
|
| Peptides | 20 | 2009 | 4392 | 0.680 |
Why?
|
| T-Box Domain Proteins | 7 | 2015 | 471 | 0.660 |
Why?
|
| Panniculitis | 1 | 2018 | 44 | 0.650 |
Why?
|
| Cell Lineage | 6 | 2021 | 2504 | 0.650 |
Why?
|
| Melanoma | 9 | 2023 | 5462 | 0.640 |
Why?
|
| Immunotherapy | 10 | 2023 | 4414 | 0.620 |
Why?
|
| Melanoma, Experimental | 7 | 2023 | 559 | 0.620 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2017 | 68 | 0.620 |
Why?
|
| Mice, Inbred BALB C | 33 | 2021 | 6382 | 0.610 |
Why?
|
| Hypersensitivity | 5 | 2022 | 1093 | 0.610 |
Why?
|
| Mice, Inbred NOD | 15 | 2015 | 1875 | 0.610 |
Why?
|
| Suppressor Factors, Immunologic | 15 | 1995 | 68 | 0.600 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 814 | 0.590 |
Why?
|
| Respiratory Hypersensitivity | 3 | 2015 | 274 | 0.590 |
Why?
|
| Flow Cytometry | 22 | 2023 | 5975 | 0.560 |
Why?
|
| Inflammasomes | 1 | 2021 | 493 | 0.560 |
Why?
|
| Lymphoma, T-Cell | 1 | 2018 | 299 | 0.550 |
Why?
|
| Intestinal Mucosa | 5 | 2023 | 3038 | 0.550 |
Why?
|
| Receptors, Interleukin-2 | 8 | 2014 | 573 | 0.550 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2016 | 121 | 0.550 |
Why?
|
| Humans | 178 | 2023 | 742088 | 0.540 |
Why?
|
| Single-Cell Analysis | 9 | 2023 | 2183 | 0.540 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2022 | 569 | 0.540 |
Why?
|
| Listeriosis | 2 | 2014 | 149 | 0.540 |
Why?
|
| Disease Models, Animal | 34 | 2023 | 18006 | 0.530 |
Why?
|
| Transcription, Genetic | 9 | 2021 | 7721 | 0.530 |
Why?
|
| Cell Proliferation | 28 | 2021 | 10472 | 0.530 |
Why?
|
| Listeria monocytogenes | 2 | 2014 | 250 | 0.530 |
Why?
|
| Interleukin-6 | 11 | 2015 | 3199 | 0.520 |
Why?
|
| Histocompatibility Antigens Class II | 14 | 2018 | 1470 | 0.520 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 7 | 2022 | 1038 | 0.520 |
Why?
|
| Immediate-Early Proteins | 3 | 2018 | 453 | 0.510 |
Why?
|
| Hybridomas | 15 | 2006 | 452 | 0.510 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2023 | 644 | 0.510 |
Why?
|
| Clone Cells | 19 | 2021 | 1692 | 0.510 |
Why?
|
| Macrophages | 12 | 2020 | 5655 | 0.500 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3564 | 0.490 |
Why?
|
| Clonal Anergy | 5 | 2015 | 169 | 0.490 |
Why?
|
| Metallothionein | 2 | 2016 | 59 | 0.490 |
Why?
|
| Homeostasis | 8 | 2023 | 3335 | 0.490 |
Why?
|
| Sodium Chloride | 2 | 2015 | 625 | 0.490 |
Why?
|
| Benzeneacetamides | 1 | 2014 | 39 | 0.490 |
Why?
|
| Immunoconjugates | 6 | 2002 | 897 | 0.490 |
Why?
|
| Antigens, Ly | 4 | 2010 | 291 | 0.480 |
Why?
|
| Oncogene Protein v-maf | 2 | 2010 | 5 | 0.480 |
Why?
|
| Immunization | 10 | 2016 | 1255 | 0.470 |
Why?
|
| Antigen Presentation | 9 | 2023 | 1284 | 0.470 |
Why?
|
| Immunity, Cellular | 12 | 2011 | 1606 | 0.460 |
Why?
|
| Mice, Inbred Strains | 21 | 2008 | 1827 | 0.460 |
Why?
|
| Pneumonia | 4 | 2019 | 2117 | 0.450 |
Why?
|
| Macrophage Activation | 7 | 2015 | 558 | 0.450 |
Why?
|
| Transcriptional Activation | 4 | 2016 | 1782 | 0.450 |
Why?
|
| Interleukin-9 | 5 | 2012 | 63 | 0.450 |
Why?
|
| Digoxin | 1 | 2014 | 250 | 0.450 |
Why?
|
| Chromatin | 6 | 2021 | 2917 | 0.450 |
Why?
|
| Receptors, Cell Surface | 5 | 2018 | 2867 | 0.440 |
Why?
|
| Thymus Gland | 5 | 2010 | 1264 | 0.430 |
Why?
|
| Smad3 Protein | 2 | 2014 | 180 | 0.430 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2012 | 44 | 0.430 |
Why?
|
| Chromosome Mapping | 8 | 2004 | 4742 | 0.430 |
Why?
|
| Neoplasms, Experimental | 7 | 2019 | 1274 | 0.420 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2015 | 1820 | 0.420 |
Why?
|
| Inflammation Mediators | 10 | 2020 | 1889 | 0.420 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 6 | 2018 | 341 | 0.410 |
Why?
|
| Trans-Activators | 4 | 2015 | 2924 | 0.410 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2012 | 209 | 0.410 |
Why?
|
| Growth Inhibitors | 2 | 2011 | 385 | 0.410 |
Why?
|
| Protein Binding | 16 | 2018 | 9387 | 0.410 |
Why?
|
| Gene Expression Profiling | 14 | 2020 | 9410 | 0.400 |
Why?
|
| Polyamines | 2 | 2022 | 120 | 0.400 |
Why?
|
| Epitopes, T-Lymphocyte | 10 | 2010 | 880 | 0.390 |
Why?
|
| Psoriasis | 2 | 2016 | 898 | 0.390 |
Why?
|
| Stem Cells | 2 | 2021 | 3563 | 0.390 |
Why?
|
| Apoptosis | 15 | 2018 | 9715 | 0.380 |
Why?
|
| Genetic Predisposition to Disease | 21 | 2015 | 17400 | 0.380 |
Why?
|
| Down-Regulation | 5 | 2014 | 3001 | 0.380 |
Why?
|
| Receptors, Interleukin-17 | 2 | 2009 | 69 | 0.380 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2009 | 221 | 0.370 |
Why?
|
| Cell Death | 3 | 2012 | 1695 | 0.370 |
Why?
|
| Models, Immunological | 5 | 2019 | 527 | 0.370 |
Why?
|
| Glycoproteins | 12 | 2012 | 2260 | 0.370 |
Why?
|
| Myeloid Cells | 3 | 2021 | 804 | 0.370 |
Why?
|
| Spleen | 10 | 2021 | 2359 | 0.360 |
Why?
|
| Immunity | 4 | 2021 | 1011 | 0.360 |
Why?
|
| Antigens, Neoplasm | 11 | 2019 | 1983 | 0.360 |
Why?
|
| Nociceptors | 3 | 2019 | 432 | 0.360 |
Why?
|
| Lymphocyte Subsets | 2 | 2021 | 315 | 0.360 |
Why?
|
| Medical Oncology | 1 | 2021 | 2235 | 0.350 |
Why?
|
| Antigens, Surface | 8 | 2011 | 1663 | 0.350 |
Why?
|
| Tretinoin | 2 | 2011 | 516 | 0.340 |
Why?
|
| Lymph Nodes | 13 | 2023 | 3465 | 0.340 |
Why?
|
| Crosses, Genetic | 5 | 2012 | 791 | 0.340 |
Why?
|
| Cattle Diseases | 7 | 1985 | 53 | 0.330 |
Why?
|
| Gene Expression | 14 | 2023 | 7790 | 0.330 |
Why?
|
| Lectins, C-Type | 4 | 2019 | 588 | 0.330 |
Why?
|
| Cell Movement | 10 | 2021 | 5212 | 0.330 |
Why?
|
| Interferon-beta | 2 | 2013 | 323 | 0.320 |
Why?
|
| Arthritis | 1 | 2014 | 658 | 0.320 |
Why?
|
| Oligopeptides | 6 | 2014 | 1176 | 0.310 |
Why?
|
| Tumor Escape | 3 | 2017 | 349 | 0.310 |
Why?
|
| Cricetinae | 9 | 2011 | 2471 | 0.310 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 840 | 0.310 |
Why?
|
| Phenotype | 17 | 2022 | 16331 | 0.310 |
Why?
|
| Antigens | 12 | 2016 | 1462 | 0.310 |
Why?
|
| GATA3 Transcription Factor | 5 | 2017 | 157 | 0.300 |
Why?
|
| Adaptive Immunity | 2 | 2012 | 712 | 0.300 |
Why?
|
| Bacterial Infections | 2 | 2018 | 1389 | 0.300 |
Why?
|
| Mice, 129 Strain | 4 | 2016 | 386 | 0.300 |
Why?
|
| Neuromyelitis Optica | 2 | 2013 | 253 | 0.300 |
Why?
|
| Killer Cells, Natural | 4 | 2014 | 2133 | 0.300 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 5851 | 0.300 |
Why?
|
| Virus Diseases | 2 | 2011 | 710 | 0.300 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 2126 | 0.300 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 17 | 2012 | 3862 | 0.290 |
Why?
|
| Female | 98 | 2021 | 379592 | 0.290 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1887 | 0.290 |
Why?
|
| Islets of Langerhans | 2 | 2006 | 1351 | 0.290 |
Why?
|
| Germinal Center | 3 | 2019 | 377 | 0.290 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2015 | 4751 | 0.290 |
Why?
|
| Thymoma | 2 | 1999 | 186 | 0.280 |
Why?
|
| Cross Reactions | 10 | 2004 | 841 | 0.280 |
Why?
|
| Exons | 2 | 2011 | 2431 | 0.280 |
Why?
|
| Immunologic Memory | 6 | 2019 | 1348 | 0.280 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2013 | 1368 | 0.280 |
Why?
|
| Immune System Diseases | 2 | 2006 | 262 | 0.270 |
Why?
|
| Immunomodulation | 3 | 2020 | 540 | 0.270 |
Why?
|
| Epitopes | 18 | 2018 | 2569 | 0.270 |
Why?
|
| Immunophenotyping | 7 | 2016 | 1866 | 0.270 |
Why?
|
| Mice, Mutant Strains | 5 | 2015 | 1866 | 0.260 |
Why?
|
| Interleukin-1beta | 5 | 2021 | 972 | 0.260 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2021 | 902 | 0.260 |
Why?
|
| Allergy and Immunology | 1 | 2006 | 169 | 0.250 |
Why?
|
| Lung | 4 | 2019 | 9826 | 0.250 |
Why?
|
| Epigenesis, Genetic | 5 | 2019 | 3639 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 8 | 2018 | 5867 | 0.250 |
Why?
|
| Up-Regulation | 11 | 2019 | 4211 | 0.250 |
Why?
|
| Phagocytosis | 4 | 2015 | 1538 | 0.250 |
Why?
|
| Phosphorylation | 7 | 2018 | 8436 | 0.240 |
Why?
|
| HEK293 Cells | 6 | 2018 | 4200 | 0.240 |
Why?
|
| Sjogren's Syndrome | 4 | 2017 | 229 | 0.230 |
Why?
|
| Feedback, Physiological | 4 | 2023 | 479 | 0.230 |
Why?
|
| Th1-Th2 Balance | 2 | 2014 | 38 | 0.220 |
Why?
|
| Self Tolerance | 3 | 2015 | 124 | 0.220 |
Why?
|
| Cell Line | 21 | 2014 | 15994 | 0.220 |
Why?
|
| Immune System | 3 | 2018 | 804 | 0.220 |
Why?
|
| DNA-Binding Proteins | 5 | 2015 | 9639 | 0.220 |
Why?
|
| Transfection | 12 | 2014 | 5892 | 0.220 |
Why?
|
| Periodicals as Topic | 2 | 2011 | 1431 | 0.220 |
Why?
|
| Laboratories | 1 | 2006 | 461 | 0.220 |
Why?
|
| Protein Conformation | 6 | 2021 | 4013 | 0.220 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2016 | 261 | 0.210 |
Why?
|
| Autophagy | 3 | 2021 | 1301 | 0.210 |
Why?
|
| Antibodies | 6 | 2013 | 2459 | 0.210 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2015 | 281 | 0.210 |
Why?
|
| Autocrine Communication | 1 | 2023 | 171 | 0.210 |
Why?
|
| Cell Adhesion Molecules | 2 | 2021 | 1599 | 0.200 |
Why?
|
| Mucin-2 | 1 | 2021 | 49 | 0.200 |
Why?
|
| Immunodominant Epitopes | 3 | 2000 | 267 | 0.200 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2020 | 20 | 0.190 |
Why?
|
| Optic Neuritis | 1 | 2003 | 166 | 0.190 |
Why?
|
| Reperfusion Injury | 4 | 2015 | 1025 | 0.190 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 16665 | 0.190 |
Why?
|
| Blood Proteins | 2 | 2004 | 1122 | 0.190 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 101 | 0.190 |
Why?
|
| Disease Susceptibility | 5 | 2015 | 1780 | 0.190 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 2015 | 0.190 |
Why?
|
| Histocompatibility Antigens | 6 | 2010 | 471 | 0.190 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4231 | 0.190 |
Why?
|
| Microglia | 4 | 2023 | 1261 | 0.190 |
Why?
|
| Mucins | 3 | 2022 | 564 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 337 | 0.180 |
Why?
|
| Rats, Inbred Lew | 5 | 2010 | 1161 | 0.180 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2023 | 547 | 0.180 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2001 | 1155 | 0.180 |
Why?
|
| H-2 Antigens | 4 | 2000 | 365 | 0.180 |
Why?
|
| Transplantation Tolerance | 3 | 2017 | 617 | 0.180 |
Why?
|
| RNA Splicing | 1 | 2005 | 907 | 0.180 |
Why?
|
| Hypersensitivity, Delayed | 10 | 1995 | 485 | 0.180 |
Why?
|
| Cell Polarity | 4 | 2021 | 644 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2020 | 3695 | 0.180 |
Why?
|
| Interleukin-18 | 1 | 2021 | 248 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 627 | 0.170 |
Why?
|
| Atrioventricular Block | 2 | 2011 | 120 | 0.170 |
Why?
|
| Lymphoid Tissue | 3 | 2011 | 455 | 0.170 |
Why?
|
| Interferon Type I | 1 | 2023 | 542 | 0.170 |
Why?
|
| Glutamine | 1 | 2022 | 574 | 0.170 |
Why?
|
| Macrophages, Peritoneal | 2 | 2010 | 251 | 0.170 |
Why?
|
| Eye Neoplasms | 5 | 1987 | 313 | 0.170 |
Why?
|
| Herpesvirus 4, Human | 2 | 2022 | 1040 | 0.170 |
Why?
|
| HLA-DR Antigens | 5 | 2017 | 644 | 0.170 |
Why?
|
| Haplotypes | 2 | 2009 | 2781 | 0.170 |
Why?
|
| Tumor Burden | 2 | 2023 | 1905 | 0.170 |
Why?
|
| Symbiosis | 1 | 2021 | 283 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1114 | 0.160 |
Why?
|
| Immunosuppressive Agents | 5 | 2011 | 4147 | 0.160 |
Why?
|
| Receptors, Scavenger | 2 | 2015 | 121 | 0.160 |
Why?
|
| Lymphocyte Count | 3 | 2017 | 792 | 0.160 |
Why?
|
| Goblet Cells | 1 | 2021 | 287 | 0.160 |
Why?
|
| Rats | 16 | 2011 | 24265 | 0.160 |
Why?
|
| Lactic Acid | 1 | 2023 | 1132 | 0.160 |
Why?
|
| Apyrase | 2 | 2013 | 364 | 0.160 |
Why?
|
| Mice, Congenic | 3 | 2011 | 99 | 0.160 |
Why?
|
| Interleukin-23 Subunit p19 | 2 | 2010 | 23 | 0.160 |
Why?
|
| Neuroimmunomodulation | 1 | 2019 | 152 | 0.160 |
Why?
|
| Cell Survival | 7 | 2018 | 5872 | 0.150 |
Why?
|
| Protein Phosphatase 1 | 1 | 2018 | 137 | 0.150 |
Why?
|
| Crystallography, X-Ray | 2 | 2021 | 2014 | 0.150 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2018 | 160 | 0.150 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2017 | 178 | 0.150 |
Why?
|
| DNA Primers | 6 | 2014 | 2892 | 0.150 |
Why?
|
| Neutrophils | 4 | 2021 | 3711 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2014 | 3744 | 0.150 |
Why?
|
| Receptor Cross-Talk | 2 | 2016 | 118 | 0.150 |
Why?
|
| Sensory Receptor Cells | 2 | 2019 | 487 | 0.140 |
Why?
|
| Blotting, Western | 6 | 2015 | 5180 | 0.140 |
Why?
|
| Fasting | 1 | 2003 | 1589 | 0.140 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2013 | 1366 | 0.140 |
Why?
|
| Superantigens | 1 | 1996 | 129 | 0.140 |
Why?
|
| Astrocytes | 2 | 2023 | 1266 | 0.140 |
Why?
|
| Male | 41 | 2021 | 349538 | 0.140 |
Why?
|
| Species Specificity | 5 | 2008 | 2479 | 0.140 |
Why?
|
| Phosphatidylserines | 2 | 2014 | 192 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2016 | 2107 | 0.140 |
Why?
|
| Fatty Acids | 2 | 2021 | 1806 | 0.140 |
Why?
|
| CHO Cells | 6 | 2002 | 1407 | 0.140 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 3133 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 314 | 0.140 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2023 | 828 | 0.140 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2015 | 32 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 3847 | 0.140 |
Why?
|
| Rosette Formation | 4 | 1983 | 153 | 0.140 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2016 | 437 | 0.140 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2015 | 42 | 0.130 |
Why?
|
| Dose-Response Relationship, Immunologic | 6 | 2011 | 370 | 0.130 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 507 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 1999 | 544 | 0.130 |
Why?
|
| Mice, Inbred DBA | 6 | 2014 | 642 | 0.130 |
Why?
|
| Genetic Vectors | 2 | 2018 | 3420 | 0.130 |
Why?
|
| Cell Compartmentation | 2 | 2021 | 402 | 0.130 |
Why?
|
| Epithelium | 2 | 2019 | 1680 | 0.130 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 226 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 65 | 0.130 |
Why?
|
| Protein Multimerization | 3 | 2021 | 971 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2016 | 15494 | 0.130 |
Why?
|
| Protein Isoforms | 3 | 2011 | 1727 | 0.130 |
Why?
|
| Enterotoxins | 1 | 1996 | 368 | 0.130 |
Why?
|
| Chromosomes, Mammalian | 1 | 2015 | 151 | 0.130 |
Why?
|
| Cloning, Molecular | 6 | 2004 | 4322 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 808 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2016 | 1825 | 0.130 |
Why?
|
| Lymphopoiesis | 1 | 2015 | 133 | 0.130 |
Why?
|
| Leptin | 1 | 2003 | 1593 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 2011 | 0.120 |
Why?
|
| Caspases | 1 | 2018 | 928 | 0.120 |
Why?
|
| Skin | 5 | 2016 | 4353 | 0.120 |
Why?
|
| Germ Cells | 1 | 2018 | 628 | 0.120 |
Why?
|
| Androstenols | 1 | 2014 | 25 | 0.120 |
Why?
|
| Horns | 4 | 1982 | 9 | 0.120 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2014 | 40 | 0.120 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2014 | 26 | 0.120 |
Why?
|
| Graft Rejection | 3 | 2022 | 4393 | 0.120 |
Why?
|
| Regeneration | 1 | 2023 | 1485 | 0.120 |
Why?
|
| Genetic Markers | 2 | 2019 | 2633 | 0.120 |
Why?
|
| Thymus Neoplasms | 1 | 1997 | 268 | 0.120 |
Why?
|
| Protein Transport | 2 | 2018 | 1988 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 9 | 1987 | 4029 | 0.120 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 171 | 0.120 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2015 | 132 | 0.120 |
Why?
|
| Keratinocytes | 2 | 2016 | 797 | 0.120 |
Why?
|
| Cell Surface Extensions | 1 | 2014 | 67 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2020 | 4414 | 0.120 |
Why?
|
| Oncolytic Viruses | 1 | 2018 | 323 | 0.120 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 427 | 0.120 |
Why?
|
| Airway Remodeling | 1 | 2015 | 132 | 0.120 |
Why?
|
| Immunoglobulin Idiotypes | 5 | 1989 | 201 | 0.120 |
Why?
|
| Diabetic Nephropathies | 1 | 2021 | 983 | 0.120 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3428 | 0.120 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1993 | 74 | 0.120 |
Why?
|
| Myelin Sheath | 3 | 2013 | 652 | 0.120 |
Why?
|
| Glioblastoma | 3 | 2018 | 3456 | 0.110 |
Why?
|
| Lymphocyte Cooperation | 1 | 2013 | 112 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2011 | 455 | 0.110 |
Why?
|
| Cell Division | 6 | 2012 | 4564 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2013 | 534 | 0.110 |
Why?
|
| Coculture Techniques | 7 | 2015 | 1341 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 2 | 2012 | 418 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 457 | 0.110 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 434 | 0.110 |
Why?
|
| Heart Block | 2 | 2005 | 410 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 561 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 2915 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 19862 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2012 | 3770 | 0.110 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2012 | 70 | 0.110 |
Why?
|
| Histones | 2 | 2021 | 2597 | 0.110 |
Why?
|
| COS Cells | 3 | 2012 | 1160 | 0.110 |
Why?
|
| Interferon-alpha | 3 | 2017 | 895 | 0.110 |
Why?
|
| RNA, Messenger | 8 | 2016 | 13029 | 0.110 |
Why?
|
| Haptens | 5 | 1995 | 166 | 0.110 |
Why?
|
| Oncolytic Virotherapy | 1 | 2018 | 490 | 0.110 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2015 | 546 | 0.110 |
Why?
|
| Collagen | 3 | 2018 | 2684 | 0.110 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 742 | 0.110 |
Why?
|
| Lymphopenia | 1 | 2014 | 285 | 0.110 |
Why?
|
| Immunity, Humoral | 2 | 2019 | 596 | 0.110 |
Why?
|
| Dopamine | 1 | 2019 | 1589 | 0.110 |
Why?
|
| Polymorphism, Genetic | 4 | 2015 | 4328 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2011 | 248 | 0.110 |
Why?
|
| Genetic Testing | 2 | 2023 | 3439 | 0.100 |
Why?
|
| HLA-DR2 Antigen | 4 | 2005 | 48 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 4 | 2015 | 2088 | 0.100 |
Why?
|
| Homeodomain Proteins | 4 | 2016 | 2417 | 0.100 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 209 | 0.100 |
Why?
|
| Connexin 43 | 1 | 2012 | 206 | 0.100 |
Why?
|
| Base Sequence | 9 | 2014 | 12797 | 0.100 |
Why?
|
| Immunoglobulins | 3 | 2005 | 880 | 0.100 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 270 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2013 | 2099 | 0.100 |
Why?
|
| Aortic Diseases | 1 | 2018 | 741 | 0.100 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2011 | 60 | 0.100 |
Why?
|
| P-Selectin | 1 | 2014 | 600 | 0.100 |
Why?
|
| RNA | 1 | 2021 | 2747 | 0.100 |
Why?
|
| Models, Biological | 3 | 2021 | 9581 | 0.100 |
Why?
|
| Nitrophenols | 5 | 1995 | 172 | 0.100 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2012 | 67 | 0.100 |
Why?
|
| Immunoassay | 2 | 2007 | 752 | 0.100 |
Why?
|
| Influenza A virus | 2 | 2011 | 456 | 0.100 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 214 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2107 | 0.100 |
Why?
|
| Hepatocytes | 2 | 2014 | 1209 | 0.100 |
Why?
|
| Jurkat Cells | 3 | 2014 | 742 | 0.100 |
Why?
|
| Galectin 1 | 1 | 2012 | 131 | 0.100 |
Why?
|
| Tuberculosis | 2 | 2016 | 1904 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1786 | 0.090 |
Why?
|
| Genetic Linkage | 3 | 2003 | 2422 | 0.090 |
Why?
|
| Phosphotyrosine | 1 | 2011 | 457 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2013 | 759 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3920 | 0.090 |
Why?
|
| Genome | 2 | 2013 | 1803 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 595 | 0.090 |
Why?
|
| Systems Biology | 1 | 2014 | 469 | 0.090 |
Why?
|
| STAT4 Transcription Factor | 1 | 2010 | 96 | 0.090 |
Why?
|
| Retroviridae | 2 | 2012 | 914 | 0.090 |
Why?
|
| HIV Infections | 2 | 2014 | 16678 | 0.090 |
Why?
|
| Citric Acid Cycle | 2 | 2021 | 231 | 0.090 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2010 | 158 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2014 | 2885 | 0.090 |
Why?
|
| Lymphocytic choriomeningitis virus | 3 | 2018 | 168 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2017 | 733 | 0.090 |
Why?
|
| Brain | 6 | 2014 | 26343 | 0.090 |
Why?
|
| Aorta | 1 | 2018 | 2057 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 434 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1119 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2713 | 0.090 |
Why?
|
| Mice, Inbred MRL lpr | 3 | 2013 | 159 | 0.090 |
Why?
|
| Melatonin | 1 | 2015 | 720 | 0.090 |
Why?
|
| Transplantation | 1 | 2011 | 217 | 0.090 |
Why?
|
| Interleukin-13 | 3 | 2019 | 389 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3585 | 0.090 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2020 | 147 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2012 | 913 | 0.090 |
Why?
|
| Eosinophils | 1 | 2014 | 953 | 0.090 |
Why?
|
| Cancer Vaccines | 2 | 2013 | 1021 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2014 | 9144 | 0.080 |
Why?
|
| Models, Molecular | 4 | 2014 | 5454 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 2013 | 1262 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2009 | 193 | 0.080 |
Why?
|
| Antibodies, Blocking | 4 | 2014 | 254 | 0.080 |
Why?
|
| Immunity, Mucosal | 2 | 2018 | 491 | 0.080 |
Why?
|
| Cricetulus | 1 | 2011 | 817 | 0.080 |
Why?
|
| Asthma | 4 | 2019 | 5955 | 0.080 |
Why?
|
| Binding Sites | 2 | 2016 | 6115 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 782 | 0.080 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 326 | 0.080 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2008 | 67 | 0.080 |
Why?
|
| Chemokines | 2 | 2021 | 954 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2010 | 291 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 571 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2010 | 345 | 0.080 |
Why?
|
| Receptors, Chemokine | 2 | 2015 | 669 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2008 | 199 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2018 | 2837 | 0.080 |
Why?
|
| RNA, Small Interfering | 4 | 2021 | 3504 | 0.080 |
Why?
|
| Plant Lectins | 1 | 1988 | 104 | 0.080 |
Why?
|
| Cell Separation | 2 | 2013 | 1749 | 0.080 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2011 | 67 | 0.080 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2009 | 58 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2170 | 0.080 |
Why?
|
| Docosahexaenoic Acids | 1 | 2014 | 875 | 0.080 |
Why?
|
| Mutagenesis | 1 | 2012 | 1263 | 0.080 |
Why?
|
| Immunoproteins | 1 | 2007 | 3 | 0.080 |
Why?
|
| Vaccination | 6 | 2017 | 3256 | 0.080 |
Why?
|
| Clonal Deletion | 2 | 2019 | 79 | 0.080 |
Why?
|
| Neoplasm Proteins | 4 | 2015 | 3691 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2012 | 2505 | 0.080 |
Why?
|
| Antibody Specificity | 5 | 2011 | 1094 | 0.080 |
Why?
|
| Fas Ligand Protein | 2 | 1999 | 217 | 0.080 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2021 | 182 | 0.080 |
Why?
|
| Lysosomes | 1 | 2012 | 893 | 0.080 |
Why?
|
| Encephalomyelitis | 1 | 2007 | 34 | 0.080 |
Why?
|
| Isoantigens | 2 | 2007 | 567 | 0.070 |
Why?
|
| Adenosine | 2 | 2014 | 823 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 6313 | 0.070 |
Why?
|
| Interleukin-5 | 2 | 2019 | 273 | 0.070 |
Why?
|
| Lysine | 2 | 2021 | 1008 | 0.070 |
Why?
|
| Spinal Cord | 2 | 2006 | 1807 | 0.070 |
Why?
|
| Dermatitis | 1 | 2009 | 197 | 0.070 |
Why?
|
| HIV | 1 | 2014 | 1600 | 0.070 |
Why?
|
| Tissue Adhesions | 1 | 2008 | 235 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2014 | 2049 | 0.070 |
Why?
|
| Skin Transplantation | 1 | 2012 | 1074 | 0.070 |
Why?
|
| Receptors, CCR6 | 2 | 2020 | 80 | 0.070 |
Why?
|
| Lupus Nephritis | 1 | 2010 | 310 | 0.070 |
Why?
|
| Cholesterol | 1 | 2015 | 2895 | 0.070 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2007 | 65 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 1210 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2015 | 2723 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2723 | 0.070 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2021 | 417 | 0.070 |
Why?
|
| Cattle | 10 | 1987 | 3923 | 0.070 |
Why?
|
| Immunoglobulin G | 4 | 2019 | 4554 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 3800 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1499 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2014 | 1252 | 0.070 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 3164 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 251 | 0.070 |
Why?
|
| 5'-Nucleotidase | 1 | 2007 | 160 | 0.070 |
Why?
|
| Receptors, CCR7 | 1 | 2006 | 108 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 11363 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 103 | 0.070 |
Why?
|
| Graft Survival | 3 | 2015 | 3733 | 0.070 |
Why?
|
| Gene Order | 2 | 2018 | 176 | 0.070 |
Why?
|
| Arthritis, Experimental | 1 | 2008 | 291 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2019 | 4282 | 0.070 |
Why?
|
| Administration, Intranasal | 2 | 2023 | 446 | 0.070 |
Why?
|
| Cell Communication | 2 | 2012 | 1619 | 0.060 |
Why?
|
| Monocytes | 2 | 2021 | 2593 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2014 | 1178 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2010 | 1586 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2011 | 1243 | 0.060 |
Why?
|
| Animals, Congenic | 1 | 2004 | 27 | 0.060 |
Why?
|
| Synovial Membrane | 1 | 2007 | 506 | 0.060 |
Why?
|
| Vertebrates | 1 | 2006 | 227 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 2 | 2019 | 259 | 0.060 |
Why?
|
| Recombinant Proteins | 6 | 2007 | 6608 | 0.060 |
Why?
|
| Receptors, CXCR3 | 2 | 2020 | 237 | 0.060 |
Why?
|
| Staining and Labeling | 2 | 2014 | 1099 | 0.060 |
Why?
|
| Freund's Adjuvant | 2 | 2015 | 139 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1788 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 1655 | 0.060 |
Why?
|
| HeLa Cells | 4 | 2014 | 3127 | 0.060 |
Why?
|
| Calcium | 4 | 2011 | 5753 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2763 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 936 | 0.060 |
Why?
|
| Fibrosarcoma | 1 | 1986 | 348 | 0.060 |
Why?
|
| Cytoplasm | 2 | 2014 | 1539 | 0.060 |
Why?
|
| Radiation Chimera | 2 | 2015 | 223 | 0.060 |
Why?
|
| Kidney | 3 | 2015 | 7167 | 0.060 |
Why?
|
| Colorectal Neoplasms | 2 | 2021 | 6754 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7901 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 659 | 0.060 |
Why?
|
| Graft vs Host Disease | 2 | 2015 | 2951 | 0.060 |
Why?
|
| Paralysis | 2 | 2005 | 249 | 0.060 |
Why?
|
| Theilovirus | 1 | 2003 | 11 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2117 | 0.060 |
Why?
|
| Lactase | 1 | 2023 | 69 | 0.060 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2002 | 29 | 0.060 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2002 | 32 | 0.060 |
Why?
|
| Ovalbumin | 4 | 2015 | 719 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 898 | 0.060 |
Why?
|
| Blotting, Northern | 3 | 1995 | 1581 | 0.060 |
Why?
|
| Optic Nerve | 1 | 2006 | 548 | 0.060 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2002 | 57 | 0.060 |
Why?
|
| Endocytosis | 2 | 2021 | 983 | 0.050 |
Why?
|
| Food Deprivation | 1 | 2003 | 116 | 0.050 |
Why?
|
| Immunization, Passive | 3 | 2001 | 625 | 0.050 |
Why?
|
| Baculoviridae | 1 | 2003 | 118 | 0.050 |
Why?
|
| Genomics | 1 | 2019 | 5692 | 0.050 |
Why?
|
| Mice, Inbred C3H | 3 | 1996 | 964 | 0.050 |
Why?
|
| Mice, Inbred CBA | 3 | 1996 | 447 | 0.050 |
Why?
|
| Carrier Proteins | 4 | 2015 | 5019 | 0.050 |
Why?
|
| Chagas Disease | 1 | 2004 | 166 | 0.050 |
Why?
|
| Demyelinating Diseases | 2 | 1996 | 363 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2003 | 210 | 0.050 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2023 | 179 | 0.050 |
Why?
|
| Trypanosoma cruzi | 1 | 2004 | 198 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 1967 | 0.050 |
Why?
|
| Multigene Family | 2 | 2002 | 1102 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2002 | 56 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2008 | 2378 | 0.050 |
Why?
|
| Peyer's Patches | 2 | 2019 | 121 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2014 | 2024 | 0.050 |
Why?
|
| Phytohemagglutinins | 1 | 1981 | 170 | 0.050 |
Why?
|
| Eflornithine | 1 | 2021 | 31 | 0.050 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1992 | 97 | 0.050 |
Why?
|
| Vaccines, DNA | 1 | 2003 | 305 | 0.050 |
Why?
|
| Putrescine | 1 | 2021 | 40 | 0.050 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2001 | 90 | 0.050 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2001 | 82 | 0.050 |
Why?
|
| Receptors, Complement 3b | 1 | 2001 | 145 | 0.050 |
Why?
|
| Ornithine Decarboxylase | 1 | 2021 | 63 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2003 | 411 | 0.050 |
Why?
|
| Aerobiosis | 1 | 2021 | 106 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2012 | 1255 | 0.050 |
Why?
|
| Research Personnel | 1 | 2006 | 573 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2023 | 279 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8626 | 0.050 |
Why?
|
| Fluorometry | 1 | 2021 | 106 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 480 | 0.050 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2001 | 143 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2002 | 1723 | 0.050 |
Why?
|
| Receptors, Complement | 1 | 2001 | 264 | 0.050 |
Why?
|
| Zinc | 1 | 2005 | 683 | 0.050 |
Why?
|
| Antigens, CD1d | 1 | 2001 | 220 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 489 | 0.050 |
Why?
|
| Fibrosis | 2 | 2021 | 2026 | 0.050 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 293 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 452 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2536 | 0.050 |
Why?
|
| Palmitic Acid | 1 | 2021 | 154 | 0.050 |
Why?
|
| Serum Albumin, Bovine | 1 | 2021 | 324 | 0.050 |
Why?
|
| Protein Phosphatase 2 | 1 | 2002 | 229 | 0.050 |
Why?
|
| Immune Sera | 1 | 2000 | 641 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2001 | 319 | 0.050 |
Why?
|
| Hyperplasia | 2 | 2016 | 1183 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2008 | 1860 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2021 | 234 | 0.050 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2021 | 154 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1575 | 0.050 |
Why?
|
| Mutation | 4 | 2021 | 29717 | 0.040 |
Why?
|
| Kinetics | 3 | 2005 | 6474 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 2 | 2000 | 1000 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2007 | 1034 | 0.040 |
Why?
|
| Optic Nerve Injuries | 1 | 2001 | 151 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2018 | 1337 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2000 | 188 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 3 | 1985 | 286 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 1221 | 0.040 |
Why?
|
| Probiotics | 1 | 2023 | 351 | 0.040 |
Why?
|
| RNA Interference | 2 | 2021 | 2890 | 0.040 |
Why?
|
| Adult | 10 | 2022 | 213712 | 0.040 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2019 | 100 | 0.040 |
Why?
|
| Antirheumatic Agents | 2 | 2020 | 1335 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2005 | 903 | 0.040 |
Why?
|
| Epithelial Cells | 3 | 2018 | 3678 | 0.040 |
Why?
|
| Pancreas | 1 | 2006 | 1684 | 0.040 |
Why?
|
| Pyroglyphidae | 1 | 2019 | 87 | 0.040 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2019 | 171 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2002 | 880 | 0.040 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2004 | 520 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2020 | 2066 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2009 | 1582 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2018 | 2751 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2014 | 3306 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2001 | 437 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 302 | 0.040 |
Why?
|
| Salmonella enterica | 1 | 2018 | 75 | 0.040 |
Why?
|
| Genes, Lethal | 2 | 2011 | 242 | 0.040 |
Why?
|
| Receptors, Cytokine | 2 | 2013 | 261 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2015 | 1547 | 0.040 |
Why?
|
| Sulfones | 1 | 2021 | 437 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 970 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 2236 | 0.040 |
Why?
|
| Salmonella Infections | 1 | 2019 | 173 | 0.040 |
Why?
|
| Proteolipids | 2 | 1995 | 117 | 0.040 |
Why?
|
| Mice, Inbred AKR | 2 | 1996 | 107 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 424 | 0.040 |
Why?
|
| Biological Transport | 1 | 2003 | 2119 | 0.040 |
Why?
|
| Phenylacetates | 4 | 1995 | 114 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 2 | 2018 | 1477 | 0.040 |
Why?
|
| Immunoglobulin D | 1 | 2017 | 56 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8425 | 0.040 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2018 | 131 | 0.040 |
Why?
|
| Amino Acids | 1 | 2004 | 1727 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1284 | 0.040 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 351 | 0.040 |
Why?
|
| Weight Loss | 2 | 2001 | 2604 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2000 | 582 | 0.040 |
Why?
|
| Computational Biology | 2 | 2019 | 3518 | 0.040 |
Why?
|
| Glycolysis | 1 | 2021 | 825 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2019 | 517 | 0.040 |
Why?
|
| Leukocyte Adherence Inhibition Test | 2 | 1987 | 6 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2007 | 4143 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2023 | 944 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 2019 | 514 | 0.040 |
Why?
|
| Erythrocytes | 2 | 1983 | 2452 | 0.040 |
Why?
|
| Integrins | 1 | 2001 | 845 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8829 | 0.040 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 235 | 0.040 |
Why?
|
| Sarcoma, Experimental | 2 | 1987 | 128 | 0.030 |
Why?
|
| Disease Progression | 3 | 2012 | 13256 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2017 | 172 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2017 | 212 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 2000 | 1159 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 838 | 0.030 |
Why?
|
| Mice, Inbred A | 1 | 1996 | 248 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2021 | 1353 | 0.030 |
Why?
|
| Lymphokines | 3 | 1990 | 949 | 0.030 |
Why?
|
| Staphylococcal Infections | 2 | 2018 | 1398 | 0.030 |
Why?
|
| p-Azobenzenearsonate | 1 | 1995 | 41 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2077 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2187 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2006 | 2924 | 0.030 |
Why?
|
| DNA | 4 | 2013 | 7289 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1998 | 547 | 0.030 |
Why?
|
| Polymers | 1 | 2003 | 1618 | 0.030 |
Why?
|
| Actins | 2 | 2014 | 2120 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2007 | 310 | 0.030 |
Why?
|
| Benzamides | 1 | 2021 | 1378 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2018 | 437 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2018 | 475 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2011 | 3497 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 2007 | 6171 | 0.030 |
Why?
|
| LLC-PK1 Cells | 1 | 2015 | 132 | 0.030 |
Why?
|
| Oligodendroglia | 2 | 2011 | 514 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2002 | 1683 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2005 | 2585 | 0.030 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2014 | 3 | 0.030 |
Why?
|
| Raffinose | 1 | 2014 | 51 | 0.030 |
Why?
|
| Sirolimus | 2 | 2016 | 1562 | 0.030 |
Why?
|
| Drug Design | 2 | 2014 | 1078 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2015 | 179 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 2024 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2021 | 3455 | 0.030 |
Why?
|
| Antigens, CD19 | 1 | 2017 | 379 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1121 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2015 | 2500 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 2014 | 94 | 0.030 |
Why?
|
| Capsaicin | 1 | 2015 | 229 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2015 | 286 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2014 | 377 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2018 | 581 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 12220 | 0.030 |
Why?
|
| Administration, Oral | 5 | 2005 | 3913 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1995 | 441 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 2938 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 2014 | 113 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6483 | 0.030 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2013 | 23 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2014 | 517 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1997 | 525 | 0.030 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2013 | 87 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2002 | 8300 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2014 | 198 | 0.030 |
Why?
|
| Conserved Sequence | 2 | 2013 | 1202 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2017 | 408 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 2014 | 292 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1460 | 0.030 |
Why?
|
| Vacuoles | 1 | 2014 | 230 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 2211 | 0.030 |
Why?
|
| Allopurinol | 1 | 2014 | 185 | 0.030 |
Why?
|
| Epidermis | 1 | 2016 | 527 | 0.030 |
Why?
|
| Nanowires | 1 | 2013 | 33 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2455 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2001 | 930 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 503 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2019 | 829 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 1835 | 0.030 |
Why?
|
| DNA Damage | 2 | 2021 | 2423 | 0.030 |
Why?
|
| Phagosomes | 1 | 2014 | 193 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 5662 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 504 | 0.030 |
Why?
|
| Organoids | 1 | 2018 | 692 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2014 | 298 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2010 | 3689 | 0.030 |
Why?
|
| Endothelium, Lymphatic | 1 | 2012 | 58 | 0.030 |
Why?
|
| Recurrence | 3 | 2015 | 8333 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 158 | 0.030 |
Why?
|
| Silicon | 1 | 2013 | 145 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2012 | 95 | 0.030 |
Why?
|
| Protein Folding | 2 | 2007 | 843 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2013 | 708 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 300 | 0.030 |
Why?
|
| Organ Preservation | 1 | 2014 | 324 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2906 | 0.030 |
Why?
|
| Lidocaine | 1 | 2015 | 542 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 586 | 0.030 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2012 | 114 | 0.030 |
Why?
|
| Response Elements | 1 | 2013 | 311 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2005 | 1245 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21719 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2012 | 464 | 0.030 |
Why?
|
| Acute-Phase Reaction | 1 | 2011 | 91 | 0.030 |
Why?
|
| Neurons | 2 | 2014 | 9325 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2011 | 116 | 0.030 |
Why?
|
| Oligonucleotides | 2 | 1991 | 572 | 0.020 |
Why?
|
| Chemokine CCL20 | 1 | 2011 | 63 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2011 | 104 | 0.020 |
Why?
|
| Immunodiffusion | 2 | 1982 | 163 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2014 | 600 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 236 | 0.020 |
Why?
|
| Stroke | 1 | 2014 | 9963 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 291 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 176 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1990 | 2255 | 0.020 |
Why?
|
| Alleles | 2 | 2015 | 6931 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1990 | 33 | 0.020 |
Why?
|
| Leukocytes | 1 | 1999 | 2039 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 241 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6365 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2014 | 670 | 0.020 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 53 | 0.020 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2011 | 144 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2015 | 980 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2014 | 475 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 733 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18355 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 849 | 0.020 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2012 | 104 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1996 | 2557 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 2018 | 854 | 0.020 |
Why?
|
| Middle Aged | 9 | 2019 | 213127 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1831 | 0.020 |
Why?
|
| Dimerization | 1 | 2012 | 893 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2012 | 608 | 0.020 |
Why?
|
| Liver | 2 | 2011 | 7470 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2018 | 62966 | 0.020 |
Why?
|
| Chemotactic Factors | 1 | 1990 | 199 | 0.020 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2012 | 279 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 822 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 317 | 0.020 |
Why?
|
| Nitrogenous Group Transferases | 1 | 2009 | 4 | 0.020 |
Why?
|
| Virus Replication | 1 | 2018 | 2531 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2010 | 223 | 0.020 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 1636 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 1449 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1675 | 0.020 |
Why?
|
| Prostatic Secretory Proteins | 1 | 1989 | 25 | 0.020 |
Why?
|
| Seasons | 1 | 2015 | 1492 | 0.020 |
Why?
|
| Podocytes | 1 | 2013 | 394 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 380 | 0.020 |
Why?
|
| Time Factors | 4 | 2015 | 40054 | 0.020 |
Why?
|
| Proteins | 2 | 2001 | 6096 | 0.020 |
Why?
|
| Light | 1 | 2015 | 1374 | 0.020 |
Why?
|
| Epigenomics | 1 | 2014 | 902 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1990 | 378 | 0.020 |
Why?
|
| Trinitrobenzenes | 1 | 1988 | 46 | 0.020 |
Why?
|
| Peritoneum | 1 | 2010 | 226 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 2014 | 1007 | 0.020 |
Why?
|
| Cisplatin | 1 | 2015 | 1637 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 611 | 0.020 |
Why?
|
| Receptors, OX40 | 1 | 2008 | 43 | 0.020 |
Why?
|
| Interleukin-16 | 1 | 2008 | 33 | 0.020 |
Why?
|
| Hepatitis A | 1 | 2009 | 133 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2011 | 551 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2012 | 671 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2008 | 183 | 0.020 |
Why?
|
| Perforin | 1 | 2008 | 168 | 0.020 |
Why?
|
| Pregnancy | 4 | 2012 | 29087 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10943 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 984 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2014 | 933 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1989 | 349 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1525 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 245 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 1988 | 258 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 2085 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2004 | 1792 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1538 | 0.020 |
Why?
|
| Granzymes | 1 | 2008 | 270 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2014 | 831 | 0.020 |
Why?
|
| Sex Factors | 1 | 2001 | 10392 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 517 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3701 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4839 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 438 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1692 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1969 | 0.020 |
Why?
|
| Genotype | 1 | 2001 | 12946 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2010 | 1034 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2015 | 2572 | 0.020 |
Why?
|
| Lectins | 1 | 1988 | 514 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15244 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 1970 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1548 | 0.020 |
Why?
|
| Interferons | 1 | 2009 | 704 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2007 | 394 | 0.020 |
Why?
|
| Glycosylation | 3 | 1997 | 1123 | 0.020 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2007 | 215 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1985 | 184 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 891 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 1985 | 135 | 0.020 |
Why?
|
| Aged | 6 | 2019 | 162944 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2005 | 81 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 2005 | 117 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2005 | 354 | 0.020 |
Why?
|
| Mast Cells | 1 | 2012 | 1544 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 5934 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2006 | 257 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7153 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1985 | 554 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 1997 | 3584 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 2906 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2007 | 784 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 2128 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 1986 | 491 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2015 | 3020 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 592 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 1989 | 1081 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2005 | 682 | 0.010 |
Why?
|
| Biophysics | 1 | 2005 | 383 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2009 | 1059 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 4771 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 2542 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 1420 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3081 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2005 | 585 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 689 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2970 | 0.010 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2008 | 744 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 15530 | 0.010 |
Why?
|
| Lipids | 1 | 2013 | 3302 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2440 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2007 | 2715 | 0.010 |
Why?
|
| Sweden | 1 | 2005 | 1343 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2003 | 375 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2012 | 2506 | 0.010 |
Why?
|
| Nerve Crush | 1 | 2001 | 79 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2008 | 3587 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7141 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 916 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2004 | 534 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 2001 | 121 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2502 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2004 | 1989 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3119 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13853 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 1009 | 0.010 |
Why?
|
| Thymectomy | 1 | 2001 | 192 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 403 | 0.010 |
Why?
|
| Insulin | 1 | 2014 | 6575 | 0.010 |
Why?
|
| Sheep | 1 | 1982 | 1437 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 1999 | 96 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2003 | 627 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 25575 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 1073 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2001 | 1386 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 1624 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2195 | 0.010 |
Why?
|
| Hindlimb | 1 | 2001 | 505 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1986 | 3139 | 0.010 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 895 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11001 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1999 | 349 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 2407 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 2968 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 424 | 0.010 |
Why?
|
| Remission Induction | 1 | 2004 | 2384 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40450 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1985 | 798 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2001 | 707 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6191 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1979 | 347 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2011 | 6440 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 35070 | 0.010 |
Why?
|
| Sepsis | 1 | 2011 | 2589 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 40955 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2008 | 9846 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2000 | 1791 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 85649 | 0.010 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1995 | 66 | 0.010 |
Why?
|
| Retinal Ganglion Cells | 1 | 2001 | 771 | 0.010 |
Why?
|
| Pyridines | 1 | 2007 | 2818 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2000 | 1961 | 0.010 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2001 | 794 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1996 | 482 | 0.010 |
Why?
|
| Mesentery | 1 | 1994 | 205 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 1170 | 0.010 |
Why?
|
| Young Adult | 2 | 2010 | 56350 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 29010 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1982 | 1065 | 0.010 |
Why?
|
| Calcimycin | 1 | 1992 | 222 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1985 | 2229 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1992 | 166 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1992 | 317 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1992 | 347 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 5097 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77478 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14720 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1992 | 821 | 0.010 |
Why?
|
| Chemokine CCL1 | 1 | 1990 | 18 | 0.010 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1990 | 43 | 0.010 |
Why?
|
| Receptors, CCR8 | 1 | 1990 | 27 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 5522 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 803 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 1990 | 291 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 549 | 0.010 |
Why?
|
| Annexins | 1 | 1989 | 38 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1989 | 344 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1989 | 363 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1988 | 237 | 0.010 |
Why?
|
| Culture Media | 1 | 1990 | 902 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1801 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 57683 | 0.000 |
Why?
|
| Viral Proteins | 1 | 1985 | 1899 | 0.000 |
Why?
|